Patient Registry Software Market Report 2025

This Patient Registry Software report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The patient registry software market size has grown rapidly in recent years. It will grow from $2.46 billion in 2024 to $2.81 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to research and clinical trials in healthcare, government initiatives to track and manage disease, adoption of electronic health records (ehrs), growth in chronic disease prevalence, need for quality reporting and performance measurement.

The patient registry software market size is expected to see rapid growth in the next few years. It will grow to $5.14 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to big data and ai in healthcare research, real-world evidence generation, genomic and precision medicine data integration, mobile and cloud-based registry solutions, regulatory requirements for data collection. Major trends in the forecast period include patient-driven data collection, integration of wearables and iot devices, data interoperability and standardization, blockchain for secure data sharing, telehealth and remote monitoring integration.

The growing adoption of electronic medical records (EMRs) is driving the expansion of the patient registry software market. An electronic medical record serves as a digital version of a patient's paper chart and can assist with billing, referrals between practices, appointment scheduling, and medication refills. Patient registry software features are often included as add-ons to EMR and EHR systems, boosting the patient registry software market. For example, in October 2023, data from the Office of the National Coordinator for Health Information Technology, a U.S. federal agency, indicated that around 60% of individuals, or roughly 3 in 5, accessed their online medical records or patient portals in 2022, with a steady increase in usage frequency over time. Furthermore, in April 2022, records from the same agency showed that by 2021, nearly 78% of office-based physicians and almost 96% of non-federal acute care hospitals had adopted certified electronic health records (EHR). Thus, the rising adoption of electronic medical records is expected to fuel the growth of the patient registry software market.

The growing use of telehealth services is expected to drive the expansion of the patient registry software market in the coming years. Telehealth involves the use of digital information and communication technologies to facilitate remote communication in clinical medical care, patient and specialist education, health management, and public health. Patient registry software can be a valuable tool in telemedicine by enhancing patient care and outcomes. It supports the management of chronic diseases, promotes clinical research, and improves population health management by providing healthcare providers with access to patient data. For example, in June 2024, the National Health Statistics Report from the Centers for Disease Control and Prevention, a U.S. federal agency, showed that telemedicine usage increased with age, from 29.4% among adults aged 18-29 to 43.3% for those 65 and older in 2021, and in 2022, usage was higher among adults aged 30 and older compared to younger adults. As a result, the rising use of telehealth services is boosting the patient registry software market.

The prominent trend is the emphasis on product innovation. Major companies in this sector are actively developing new product innovations to bolster their market positions. For example, in January 2022, Seqster PDM, Inc., a U.S.-based healthcare company specializing in comprehensive patient records, partnered with the National Pancreas Foundation to create registry software that collects data using remote monitoring devices. This collaboration leverages Seqster's technology to combine patient information from wearable/remote monitoring devices, genomic DNA tests, and EHR in real-time, facilitating more comprehensive and coordinated care. The National Pancreas Foundation (NPCF), a non-profit organization providing support for those affected by pancreatic cancer, is actively involved in this initiative.

Major companies in the patient registry software market are actively developing innovative products, including contact registries, to better serve their existing consumers. Contact registries, which store contact details for specific groups of individuals, serve various purposes, such as emergency management, clinical trial patient recruitment, and disease surveillance. For instance, in March 2022, the Rare Diseases Clinical Research Network, a non-profit organization supported by the National Institutes of Health (NIH), introduced a contact registry to connect patients with rare diseases to researchers, enhancing rare disease research. This registry, managed by the Rare Diseases Clinical Research Network (RDCRN), aims to keep participants informed about available research opportunities while gathering and storing their contact details.

In October 2023, Access Healthcare, an India-based revenue cycle management (RCM) and healthcare services company, acquired Envera Health for an undisclosed amount. Through this acquisition, Access Healthcare aims to integrate Envera's patient engagement capabilities, enhancing its end-to-end RCM service delivery while further improving its proprietary workflows and process intelligence platform. Envera Health is a U.S.-based company offering human + tech engagement services, providing a connectivity ecosystem designed to strengthen health systems and physician practices.

Major companies operating in the patient registry software market include Armus Digital Pvt. Ltd., Dacima Software Inc., Evado Clinical, Global Vision Technology Co. Ltd., Gz Technology Pvt. Ltd., Healthmonix LLC, Imagetrend Inc., QVIA Holdings Inc., Lumedx Healthcare Technologies Private Limited, M2s Industries Private Limited, Mckesson Corporation, Opentext Corporation, Optum Health & Technology Private Limited, Phytel Inc., Premier Inc., Syneos Health Inc., Telligen Inc., Advarra Inc., Advera Health Analytics, ArborMetrix Inc., EResearch Technology, FIGmd Inc., Flatiron Health Inc., Healex Systems Ltd., IFA Systems AG, Liaison Technologies Inc., Medrio Inc., Molecular Corp., OM1 Inc., Open Registry, Orion Health Corp., PatientCrossroads, PatientRegistry.

North America was the largest region in the patient registry software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient registry software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Patient registry software is a structured system designed for gathering non-clinical or clinical patient data to evaluate specific outcomes using observational study methodologies.

The main types of products in patient registry software include integrated software and standalone software. The various types of databases include disease registries, health service registries, and product registries. Disease registries focus on a specific disease or condition as the inclusion criterion, serving as a unique database that includes data on individuals diagnosed with a particular disease type. Different deployment models are available, including on-premise and cloud-based solutions, with functionalities encompassing population health management, patient care management, medical research and clinical studies, health information exchange, point-of-care services, and product outcome evaluation. Patient registry software is employed by various entities, including government organizations and third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, as well as research centers.

The patient registry software market research report is one of a series of new reports that provides patient registry software market statistics, including patient registry software industry global market size, regional shares, competitors with patient registry software market share, detailed patient registry software market segments, market trends and opportunities, and any further data you may need to thrive in the patient registry software industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient registry software market consists of sales of software and services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.